Overview
An AI model designed to identify abnormalities in breast MRI scans has demonstrated remarkable accuracy in locating tumors, surpassing traditional benchmark models in a recent study published in Radiology, the journal of the Radiological Society of North America (RSNA).
Key Findings
- The AI model effectively identified tumor locations in breast MR images.
- It outperformed existing models when tested across three distinct groups.
- Lead investigator Dr. Felipe Oviedo from Microsoft’s AI for Good Lab emphasized the potential of AI-assisted MRI to detect cancers that may be overlooked by human radiologists.
Background
Screening mammography is the standard method for breast cancer detection, but it is less effective for women with dense breast tissue, which can obscure tumors. In such cases, breast MRI is often recommended as a supplementary screening tool.
Dr. Oviedo noted that while MRI is more sensitive than mammography, it is also more costly and has a higher rate of false positives.
Research Development
To improve the accuracy and efficiency of breast MRI screenings, Dr. Oviedo’s team collaborated with clinical investigators at the University of Washington to create an explainable AI anomaly detection model. This model is designed to differentiate between normal and abnormal data, highlighting anomalies for further examination.
Previous models were criticized for their unrealistic training data distribution, which consisted of equal parts cancer and normal cases. This study aimed to address those limitations by training the model on nearly 10,000 breast MRI exams conducted between 2005 and 2022.
Model Performance
The anomaly detection model not only provides an estimated anomaly score but also generates a spatially resolved heatmap for each MRI image. This heatmap visually indicates areas that the model identifies as abnormal, aligning closely with biopsy-confirmed malignancies annotated by radiologists.
The model was validated using both internal and external datasets, demonstrating its ability to accurately depict tumor locations and outperform benchmark models in various detection tasks.
Implications for Radiology
If integrated into clinical workflows, this AI model could streamline the triage process by excluding normal scans, thereby enhancing reading efficiency for radiologists. Dr. Oviedo stated, “Our model offers a clear, pixel-level explanation of abnormalities in breast images, allowing radiologists to concentrate on exams with a higher likelihood of cancer.”
Before clinical implementation, further evaluation in larger datasets and prospective studies is necessary to fully assess the model’s impact on radiologists’ workflows.
Reference
For more details, refer to the article titled Cancer Detection in Breast MRI Screening via Explainable AI Anomaly Detection in Radiology.